Anticoagulation: Clinical Trials

1 trial for Anticoagulation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Anticoagulation: new trials by email Literature Review of Anticoagulation trials Research Report on Anticoagulation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation
CVVH with Phoxilium® in the first 48h after randomization, CVVH with Biphozyl® in the first 48h after randomization, CVVH with Phoxilium® in the second 48h after randomization (after previous 48h with Biphozyl®) - Critically Ill, Acute Kidney Injury
Phase 2CompletedMedical University Innsbruck882020-08-012024-03-13

Narrower conditions

Acute Kidney Injury (1)  ·  Critical Illness (1)

Broader conditions

Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Sponsors

Medical University Innsbruck (1)

Countries

Austria (1)

Top investigators

Michael Joannidis, Univ.-Prof., MD (1)

Results publications

PMID 40759107, PMID 41247497